WHO ICTRP trial
A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of…
ACTRN12625001353482 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12625001353482 |
|---|---|
| Public title | A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GS-3107 Coadministered with Encequidar in Healthy Participants |
| Scientific title | A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GS-3107 Coadministered with Encequidar in Healthy Participants |
| Primary sponsor | Gilead Sciences Inc |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | New Zealand |
| Conditions | HIV-1 Infection; HIV-1 Infection;Infection - Acquired immune deficiency syndrome (AIDS / HIV) |
| Interventions | The study will proceed governed by a review of safety and available PK data and applicable stopping rules. Each cohort is open label with no arms within each cohort. Dose selection, dose frequency, dose and meal conditions will be… |
| Registration date | Mar 12, 2025 |
| Target size | 16 |
| Secondary IDs | GS-US-756-7894 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: